Sale of 3,035 shares at $10.77 per share.
Reporting Person Kaiser Peter · Officer Title Chief Development Officer · Transaction Code S
Traded Aug 24, 2026 · Disclosed Aug 26, 2026
Source: SEC Form 4 · 0001104659-26-101674 · filed 2026-08-26 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "OCULAR THERAPEUTIX, INC (OCUL)." Disclosed 2026-08-26. https://desqlong.com/cards/0001104659-26-101674-1 (retrieved 2026-09-26).